Wealth Enhancement Trust Services’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72K Buy
+135
New +$1.74K ﹤0.01% 1023

Other funds holding TNXP

Wealth Enhancement Trust Services's TNXP Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 135 shares worth $1.72K. The stake represents ﹤0.01% of the portfolio and ranks #1023 among its holdings.

13 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Wealth Enhancement Trust Services held 135 shares of Tonix Pharmaceuticals worth $1.72K as of Q2 2026.
  • Tonix Pharmaceuticals was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1023 holding.
  • 13 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.